Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Devlin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The Patient|November 29, 2014
Adopting a Sustainable Community of Practice Model when Developing a Service to Support Patients with Epidermolysis Bullosa (EB): A Stakeholder-Centered ApproachRosemary Joan Gowran, Avril Kennan, Siobhán Marshall, et al.
Chemical Communications (Cambridge, England)|April 9, 2015
A fluorescent histone deacetylase (HDAC) inhibitor for cellular imagingCassandra L Fleming, Trent D Ashton, Cameron Nowell, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 11, 2010
Cleft lip/palate: incidence of prenatal diagnosis in Glasgow, Scotland, and comparison with other centers in the United KingdomPaul Paterson, Haroon Sher, Faye Wylie, et al.
Clinical & Experimental Metastasis|December 15, 2012
LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in miceRong Li, Judy Doherty, Juliana Antonipillai, et al.
European Journal of Medicinal Chemistry|November 19, 2018
Highly fluorescent and HDAC6 selective scriptaid analoguesCassandra L Fleming, Anthony Natoli, Jeannette Schreuders, et al.
Applied Optics|March 10, 2021
The Simons Observatory: metamaterial microwave absorber and its cryogenic applicationsZhilei Xu, Grace E Chesmore, Shunsuke Adachi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
Applied Optics|March 10, 2021
The Simons Observatory: modeling optical systematics in the Large Aperture TelescopeJon E Gudmundsson, Patricio A Gallardo, Roberto Puddu, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Patient|November 29, 2014
Adopting a Sustainable Community of Practice Model when Developing a Service to Support Patients with Epidermolysis Bullosa (EB): A Stakeholder-Centered ApproachRosemary Joan Gowran, Avril Kennan, Siobhán Marshall, et al.
Chemical Communications (Cambridge, England)|April 9, 2015
A fluorescent histone deacetylase (HDAC) inhibitor for cellular imagingCassandra L Fleming, Trent D Ashton, Cameron Nowell, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|September 11, 2010
Cleft lip/palate: incidence of prenatal diagnosis in Glasgow, Scotland, and comparison with other centers in the United KingdomPaul Paterson, Haroon Sher, Faye Wylie, et al.
Clinical & Experimental Metastasis|December 15, 2012
LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in miceRong Li, Judy Doherty, Juliana Antonipillai, et al.
European Journal of Medicinal Chemistry|November 19, 2018
Highly fluorescent and HDAC6 selective scriptaid analoguesCassandra L Fleming, Anthony Natoli, Jeannette Schreuders, et al.
Applied Optics|March 10, 2021
The Simons Observatory: metamaterial microwave absorber and its cryogenic applicationsZhilei Xu, Grace E Chesmore, Shunsuke Adachi, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Cell Death & Disease|March 13, 2021
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumorsChristoph Grohmann, Francesca Walker, Mark Devlin, et al.
Applied Optics|March 10, 2021
The Simons Observatory: modeling optical systematics in the Large Aperture TelescopeJon E Gudmundsson, Patricio A Gallardo, Roberto Puddu, et al.
Cell Chemical Biology|August 9, 2023
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancerShikhar Sharma, Chi-Yeh Chung, Sean Uryu, et al.
Pageof 2